| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/09/2023 | Tenaya Therapeutics, Inc. | | Grant | Stock Option (Right to buy) | 29.5k | $7.12 | $210.3k | | 06/09/2023 |
| 06/08/2023 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 25k | $4.83 | $120.8k | | 06/08/2023 |
| 05/24/2023 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 24.9k | $13.49 | $335.9k | | 05/24/2023 |
| 07/05/2022 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 7.2k | $5.54 | $40k | | 07/05/2022 |
| 06/10/2022 | Tenaya Therapeutics, Inc. | | Grant | Stock Option (Right to buy) | 39.7k | $5.26 | $209k | | 06/10/2022 |
| 06/09/2022 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 19.2k | $6.19 | $118.8k | | 06/09/2022 |
| 06/03/2022 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $4.58 | $89.7k | | 06/03/2022 |
| 06/09/2021 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 15k | $26.59 | $398.8k | | 06/09/2021 |
| 05/26/2021 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $19.56 | $383.3k | | 05/26/2021 |
| 09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 35.6k | $0.00 | $0 | | 07/31/2020 |
| 09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 10.7k | $0.00 | $0 | | 07/31/2020 |
| 08/07/2020 | Dyne Therapeutics, Inc. | | Purchase | Series B Preferred Stock | 35.6k | $2.81 | $100k | | 07/31/2020 |
| 07/31/2020 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 14.4k | $5.54 | $80k | | 07/31/2020 |
| 07/31/2020 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 11.2k | $5.54 | $61.8k | | 07/31/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Conversion | Series C Preferred Stock | 8.9k | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Conversion | Common Stock | 5.1k | $0.00 | $0 | | 06/16/2020 |
| 06/11/2020 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 52k | $19.00 | $988k | | 06/11/2020 |
| 04/03/2017 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock Option (right to buy) | 100k | $29.70 | $3M | | 04/03/2017 |